Sfoglia per Autore
Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the Results of a European Survey
2023-01-01 Tagliamento, Marco; Remon, Jordi; Giaj Levra, Matteo; De Maria, Andrea; Bironzo, Paolo; Besse, Benjamin; Novello, Silvia; Mezquita, Laura
Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey
2022-01-01 Pilotto, Sara; Avancini, Alice; Menis, Jessica; Sperduti, Isabella; Giaj Levra, Matteo; Berghmans, Thierry; Bironzo, Paolo; Brandão, Mariana; De Ruysscher, Dirk; Edwards, John; Faivre-Finn, Corinne; Girard, Nicolas; Greillier, Laurent; Hendriks, Lizza; Lantuejoul, Sylvie; Mauer, Murielle; Novello, Silvia; O'Brien, Mary; Reck, Martin; Reguart, Noemi; Remon, Jordi; von der Thüsen, Jan; Dingemans, Anne-Marie C; Besse, Benjamin; Milella, Michele
Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers
2022-01-01 Mc Leer A.; Foll M.; Brevet M.; Antoine M.; Novello S.; Mondet J.; Cadranel J.; Girard N.; Giaj Levra M.; Demontrond P.; Audigier-Valette C.; Letouze E.; Lantuejoul S.; Fernandez-Cuesta L.; Moro-Sibilot D.
A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics
2019-01-01 Ferrer, Léonie; Giaj Levra, Matteo; Brevet, Marie; Antoine, Martine; Mazieres, Julien; Rossi, Giulio; Chiari, Rita; Westeel, Virginie; Poudenx, Michel; Letreut, Jacques; Gervais, Radj; Osman, Giorgia; Girard, Nicolas; Toffart, Anne Claire; Novello, Silvia; Moro-Sibilot, Denis*
Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion
2019-01-01 Hendriks L.E.L.; Dooms C.; Berghmans T.; Novello S.; Levy A.; De Ruysscher D.; Hasan B.; Giaj Levra M.; Giaj Levra N.; Besse B.; Vansteenkiste J.; Dingemans A.-M.C.
Defining Synchronous Oligometastatic Non–Small Cell Lung Cancer: A Systematic Review
2019-01-01 Giaj-Levra N.; Giaj-Levra M.; Durieux V.; Novello S.; Besse B.; Hasan B.; Hendriks L.E.; Levy A.; Dingemans A.-M.C.; Berghmans T.
Definition of synchronous oligo-metastatic non-small cell lung cancer - a consensus report
2019-01-01 Dingemans, Anne-Marie C; Hendriks, Lizza E L; Berghmans, Thierry; Levy, Antonin; Hasan, Baktiar; Faivre-Finn, Corinne; Giaj-Levra, Matteo; Giaj-Levra, Niccolò; Girard, Nicolas; Greillier, Laurent; Lantuéjoul, Sylvie; Edwards, John; O'Brien, Mary; Reck, Martin; Smit, Egbert F; Van Schil, Paul; Postmus, Pieter E; Ramella, Sara; Lievens, Yolande; Gaga, Mina; Peled, Nir; Scagliotti, Giorgio V; Senan, Suresh; Paz-Ares, Luiz; Guckenberger, Matthias; McDonald, Fiona; Ekman, Simon; Cufer, Tanja; Gietema, Hester; Infante, Maurizio; Dziadziuszko, Rafal; Peters, Solange; Porta, Ramon Rami; Vansteenkiste, Johan; Dooms, Christophe; de Ruysscher, Dirk; Besse, Benjamin; Novello, Silvia
Oligometastatic non-small cell lung cancer (NSCLC): Does number of metastasis matter?
2019-01-01 Giaj-Levra N.; Giaj Levra M.; Berghmans T.; Novello S.; Hendriks L.E.; Levy A.; Besse B.; Dingemans A.-M.C.
Women with synchronous or metachronous lung and ovarian cancer: A multi-institutional report
2019-01-01 Mariniello A.; Ghisoni E.; Righi L.; Catino A.; Chiari R.; Del Conte A.; Barbieri F.; Cecere F.; Gelibter A.; Giajlevra M.; Parra H.S.; Zichi C.; Maio M.D.I.; Valabrega G.; Novello S.
EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease
2019-01-01 Levy A.; Hendriks L.E.L.; Berghmans T.; Faivre-Finn C.; GiajLevra M.; GiajLevra N.; Hasan B.; Pochesci A.; Girard N.; Greillier L.; Lantuejoul S.; Edwards J.; O'Brien M.; Reck M.; Besse B.; Novello S.; Dingemans A.-M.C.
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
2016-01-01 Novello, S; Barlesi, F; Califano, R; Cufer, T; Ekman, S; Levra, Mg; Kerr, K; Popat, S; Reck, M; Senan, S; Simo, Gv; Vansteenkiste, J; Peters, S; ESMO Guidelines Committee
Primary pleuropulmonary sarcoma: what we know about it?
2014-01-01 M Giaj Levra; S Novello; A Le Cesne
Lung cancer in never smokers: a different disease
2014-01-01 T Vavalà; M Giaj Levra; S Novello
Activity of the EGFR-HER2 dual inhibitor afatinib in EGFR-mutant lung cancer patients with acquired resistance to reversible EGFR tyrosine kinase inhibitors.
2014-01-01 Landi L;Tiseo M;Chiari R;Ricciardi S;Rossi E;Galetta D;Novello S;Milella M;D'Incecco A;Minuti G;Tibaldi C;Salvini J;Facchinetti F;Haspinger ER;Cortinovis D;Santo A;Banna G;Catino A;GiajLevra M;Crinò L;de Marinis F;Cappuzzo F
PARP inhibitors: an interesting pathway also for non-small cell lung cancer?
2014-01-01 Levra MG;Olaussen KA;Novello S;Soria JC
Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial
2014-01-01 Vanesa Gregorc;Silvia Novello;Chiara Lazzari;Sandro Barni;Michele Aieta;Manlio Mencoboni;Francesco Grossi;Tommaso De Pas;Filippo de Marinis;Alessandra Bearz;Irene Floriani;Valter Torri;Alessandra Bulotta;Angela Cattaneo;Julia Grigorieva;Maxim Tsypin;Joanna Roder;Claudio Doglioni;Matteo Giaj Levra;Fausto Petrelli;Silvia Foti;Mariagrazia Viganò;Angela Bachi;Heinrich Roder
Extending survival of stage IV non-small cell lung cancer.
2014-01-01 Carnio S;Novello S;Mele T; Giaj Levra Matteo; Scagliotti GV
Clinical Implications and Added Costs of Incidental Findings in an Early Detection Study of Lung Cancer by Using Low-Dose Spiral Computed Tomography.
2013-01-01 AM Priola;SM Priola; M Giaj-Levra; E Basso;A Veltri; C Fava; L Cardinale
PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicine.
2013-01-01 Pilotto S; Peretti U; Novello S; Rossi G; Milella M; Giaj Levra M; Ciuffreda L; Massari F; Brunelli M; Tortora G; Bria E.
Clinical meta-analyses of targeted therapies in adenocarcinoma
2013-01-01 Bria E; Bonomi M; Pilotto S; Massari F; Novello S; Levra MG; Tortora G; Scagliotti G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the Results of a European Survey | 2023 | Tagliamento, Marco; Remon, Jordi; Giaj Levra, Matteo; De Maria, Andrea; Bironzo, Paolo; Besse, Benjamin; Novello, Silvia; Mezquita, Laura | |
| Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey | 2022 | Pilotto, Sara; Avancini, Alice; Menis, Jessica; Sperduti, Isabella; Giaj Levra, Matteo; Berghmans, Thierry; Bironzo, Paolo; Brandão, Mariana; De Ruysscher, Dirk; Edwards, John; Faivre-Finn, Corinne; Girard, Nicolas; Greillier, Laurent; Hendriks, Lizza; Lantuejoul, Sylvie; Mauer, Murielle; Novello, Silvia; O'Brien, Mary; Reck, Martin; Reguart, Noemi; Remon, Jordi; von der Thüsen, Jan; Dingemans, Anne-Marie C; Besse, Benjamin; Milella, Michele | |
| Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers | 2022 | Mc Leer A.; Foll M.; Brevet M.; Antoine M.; Novello S.; Mondet J.; Cadranel J.; Girard N.; Giaj Levra M.; Demontrond P.; Audigier-Valette C.; Letouze E.; Lantuejoul S.; Fernandez-Cuesta L.; Moro-Sibilot D. | |
| A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics | 2019 | Ferrer, Léonie; Giaj Levra, Matteo; Brevet, Marie; Antoine, Martine; Mazieres, Julien; Rossi, Giulio; Chiari, Rita; Westeel, Virginie; Poudenx, Michel; Letreut, Jacques; Gervais, Radj; Osman, Giorgia; Girard, Nicolas; Toffart, Anne Claire; Novello, Silvia; Moro-Sibilot, Denis* | |
| Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion | 2019 | Hendriks L.E.L.; Dooms C.; Berghmans T.; Novello S.; Levy A.; De Ruysscher D.; Hasan B.; Giaj Levra M.; Giaj Levra N.; Besse B.; Vansteenkiste J.; Dingemans A.-M.C. | |
| Defining Synchronous Oligometastatic Non–Small Cell Lung Cancer: A Systematic Review | 2019 | Giaj-Levra N.; Giaj-Levra M.; Durieux V.; Novello S.; Besse B.; Hasan B.; Hendriks L.E.; Levy A.; Dingemans A.-M.C.; Berghmans T. | |
| Definition of synchronous oligo-metastatic non-small cell lung cancer - a consensus report | 2019 | Dingemans, Anne-Marie C; Hendriks, Lizza E L; Berghmans, Thierry; Levy, Antonin; Hasan, Baktiar; Faivre-Finn, Corinne; Giaj-Levra, Matteo; Giaj-Levra, Niccolò; Girard, Nicolas; Greillier, Laurent; Lantuéjoul, Sylvie; Edwards, John; O'Brien, Mary; Reck, Martin; Smit, Egbert F; Van Schil, Paul; Postmus, Pieter E; Ramella, Sara; Lievens, Yolande; Gaga, Mina; Peled, Nir; Scagliotti, Giorgio V; Senan, Suresh; Paz-Ares, Luiz; Guckenberger, Matthias; McDonald, Fiona; Ekman, Simon; Cufer, Tanja; Gietema, Hester; Infante, Maurizio; Dziadziuszko, Rafal; Peters, Solange; Porta, Ramon Rami; Vansteenkiste, Johan; Dooms, Christophe; de Ruysscher, Dirk; Besse, Benjamin; Novello, Silvia | |
| Oligometastatic non-small cell lung cancer (NSCLC): Does number of metastasis matter? | 2019 | Giaj-Levra N.; Giaj Levra M.; Berghmans T.; Novello S.; Hendriks L.E.; Levy A.; Besse B.; Dingemans A.-M.C. | |
| Women with synchronous or metachronous lung and ovarian cancer: A multi-institutional report | 2019 | Mariniello A.; Ghisoni E.; Righi L.; Catino A.; Chiari R.; Del Conte A.; Barbieri F.; Cecere F.; Gelibter A.; Giajlevra M.; Parra H.S.; Zichi C.; Maio M.D.I.; Valabrega G.; Novello S. | |
| EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease | 2019 | Levy A.; Hendriks L.E.L.; Berghmans T.; Faivre-Finn C.; GiajLevra M.; GiajLevra N.; Hasan B.; Pochesci A.; Girard N.; Greillier L.; Lantuejoul S.; Edwards J.; O'Brien M.; Reck M.; Besse B.; Novello S.; Dingemans A.-M.C. | |
| Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | 2016 | Novello, S; Barlesi, F; Califano, R; Cufer, T; Ekman, S; Levra, Mg; Kerr, K; Popat, S; Reck, M; Senan, S; Simo, Gv; Vansteenkiste, J; Peters, S; ESMO Guidelines Committee | |
| Primary pleuropulmonary sarcoma: what we know about it? | 2014 | M Giaj Levra; S Novello; A Le Cesne | |
| Lung cancer in never smokers: a different disease | 2014 | T Vavalà; M Giaj Levra; S Novello | |
| Activity of the EGFR-HER2 dual inhibitor afatinib in EGFR-mutant lung cancer patients with acquired resistance to reversible EGFR tyrosine kinase inhibitors. | 2014 | Landi L;Tiseo M;Chiari R;Ricciardi S;Rossi E;Galetta D;Novello S;Milella M;D'Incecco A;Minuti G;Tibaldi C;Salvini J;Facchinetti F;Haspinger ER;Cortinovis D;Santo A;Banna G;Catino A;GiajLevra M;Crinò L;de Marinis F;Cappuzzo F | |
| PARP inhibitors: an interesting pathway also for non-small cell lung cancer? | 2014 | Levra MG;Olaussen KA;Novello S;Soria JC | |
| Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial | 2014 | Vanesa Gregorc;Silvia Novello;Chiara Lazzari;Sandro Barni;Michele Aieta;Manlio Mencoboni;Francesco Grossi;Tommaso De Pas;Filippo de Marinis;Alessandra Bearz;Irene Floriani;Valter Torri;Alessandra Bulotta;Angela Cattaneo;Julia Grigorieva;Maxim Tsypin;Joanna Roder;Claudio Doglioni;Matteo Giaj Levra;Fausto Petrelli;Silvia Foti;Mariagrazia Viganò;Angela Bachi;Heinrich Roder | |
| Extending survival of stage IV non-small cell lung cancer. | 2014 | Carnio S;Novello S;Mele T; Giaj Levra Matteo; Scagliotti GV | |
| Clinical Implications and Added Costs of Incidental Findings in an Early Detection Study of Lung Cancer by Using Low-Dose Spiral Computed Tomography. | 2013 | AM Priola;SM Priola; M Giaj-Levra; E Basso;A Veltri; C Fava; L Cardinale | |
| PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicine. | 2013 | Pilotto S; Peretti U; Novello S; Rossi G; Milella M; Giaj Levra M; Ciuffreda L; Massari F; Brunelli M; Tortora G; Bria E. | |
| Clinical meta-analyses of targeted therapies in adenocarcinoma | 2013 | Bria E; Bonomi M; Pilotto S; Massari F; Novello S; Levra MG; Tortora G; Scagliotti G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile